TY - JOUR
T1 - Long non-coding RNAs in motor neuron development and disease
AU - Vangoor, Vamshidhar R.
AU - Gomes-Duarte, Andreia
AU - Pasterkamp, R. Jeroen
N1 - Funding Information:
The authors thank Jan Veldink for critically reading the manuscript. This work was supported by the ALS Stichting Nederland (TOTALS, ALS‐on‐a‐chip), the Dutch Epilepsiefonds (WAR 18‐05) and the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska‐Curie grant agreement No. 721890 (circRTrain ITN).
Publisher Copyright:
© 2020 The Authors. Journal of Neurochemistry published by John Wiley & Sons Ltd on behalf of International Society for Neurochemistry
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - Long non-coding RNAs (lncRNAs) are RNAs that exceed 200 nucleotides in length and that are not translated into proteins. Thousands of lncRNAs have been identified with functions in processes such as transcription and translation regulation, RNA processing, and RNA and protein sponging. LncRNAs show prominent expression in the nervous system and have been implicated in neural development, function and disease. Recent work has begun to report on the expression and roles of lncRNAs in motor neurons (MNs). The cell bodies of MNs are located in cortex, brainstem or spinal cord and their axons project into the brainstem, spinal cord or towards peripheral muscles, thereby controlling important functions such as movement, breathing and swallowing. Degeneration of MNs is a pathological hallmark of diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy. LncRNAs influence several aspects of MN development and disruptions in these lncRNA-mediated effects are proposed to contribute to the pathogenic mechanisms underlying MN diseases (MNDs). Accumulating evidence suggests that lncRNAs may comprise valuable therapeutic targets for different MNDs. In this review, we discuss the role of lncRNAs (including circular RNAs [circRNAs]) in the development of MNs, discuss how lncRNAs may contribute to MNDs and provide directions for future research.
AB - Long non-coding RNAs (lncRNAs) are RNAs that exceed 200 nucleotides in length and that are not translated into proteins. Thousands of lncRNAs have been identified with functions in processes such as transcription and translation regulation, RNA processing, and RNA and protein sponging. LncRNAs show prominent expression in the nervous system and have been implicated in neural development, function and disease. Recent work has begun to report on the expression and roles of lncRNAs in motor neurons (MNs). The cell bodies of MNs are located in cortex, brainstem or spinal cord and their axons project into the brainstem, spinal cord or towards peripheral muscles, thereby controlling important functions such as movement, breathing and swallowing. Degeneration of MNs is a pathological hallmark of diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy. LncRNAs influence several aspects of MN development and disruptions in these lncRNA-mediated effects are proposed to contribute to the pathogenic mechanisms underlying MN diseases (MNDs). Accumulating evidence suggests that lncRNAs may comprise valuable therapeutic targets for different MNDs. In this review, we discuss the role of lncRNAs (including circular RNAs [circRNAs]) in the development of MNs, discuss how lncRNAs may contribute to MNDs and provide directions for future research.
KW - amyotrophic lateral sclerosis
KW - circular RNA
KW - long non-coding RNA
KW - motor neuron development
KW - spinal muscular atrophy
UR - https://www.scopus.com/pages/publications/85092292135
U2 - 10.1111/jnc.15198
DO - 10.1111/jnc.15198
M3 - Review article
C2 - 32970857
AN - SCOPUS:85092292135
SN - 0022-3042
VL - 156
SP - 777
EP - 801
JO - Journal of Neurochemistry
JF - Journal of Neurochemistry
IS - 6
ER -